HRT Financial’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-40,700
Closed -$7.55M 3602
2025
Q3
$7.55M Buy
40,700
+12,800
+46% +$2.19M 0.03% 493
2025
Q2
$4.26M Buy
27,900
+17,700
+174% +$2.72M 0.02% 604
2025
Q1
$1.69M Buy
+10,200
New +$1.6M 0.01% 883
2023
Q4
Sell
-3,300
Closed -$513K 2709
2023
Q3
$513K Buy
+3,300
New +$545K 0.01% 1393
2022
Q1
Sell
-1,400
Closed -$239K 3466
2021
Q4
$239K Buy
+1,400
New +$229K ﹤0.01% 2420
2021
Q2
Sell
-12,900
Closed -$2.12M 3181
2021
Q1
$2.12M Buy
+12,900
New +$2.09M 0.02% 582

Other funds holding JNJ

HRT Financial's JNJ Position: Q1 2026 in Review

HRT Financial sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 14,989 shares — an estimated $3.49M sold.

HRT Financial first reported a position in JNJ in Q4 2014 and held it in 27 quarters. The position peaked at $223M in Q3 2025. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • HRT Financial reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 14,989 Johnson & Johnson shares in Q1 2026, an estimated $3.49M.
  • HRT Financial first reported a position in Johnson & Johnson in Q4 2014 and held it in 27 quarters.
  • HRT Financial's Johnson & Johnson position peaked at $223M in Q3 2025.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.